Larimar Therapeutics Inc. buy tamam
Start price
05.05.17
/
50%
€56.41
Target price
22.05.17
€64.94
Performance (%)
-21.33%
End price
22.05.17
€44.38
Summary
This prediction ended on 22.05.17 with a price of €44.38. The price of Larimar Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.33%. tamam has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Larimar Therapeutics Inc. | -5.495% | -5.495% | 213.869% | 3.614% |
iShares Core DAX® | -0.612% | 0.567% | 12.585% | 14.838% |
iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% | 38.328% |
iShares Nikkei 225® | -2.647% | 0.330% | 9.482% | 5.652% |
iShares S&P 500 | -1.932% | -1.126% | 23.191% | 38.791% |
Comments by tamam for this prediction
In the thread Zafgen Inc. diskutieren
(Vom Mitglied beendet)